Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.

The Ozempic maker's stock tanked after its highly anticipated CagriSema drug trial showed an average of 22.7% weight loss, ...

Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Novo Nordisk (NVO) released mixed clinical-trial results for its potential Ozempic successor on Friday, leaving Wall Street ...

But in an increasingly competitive market for weight loss drugs, these are not the only options for people looking to lose ...

Ozempic before and after photos show weight loss. Women share what it's like to lose weight with Ozempic and Wegovy, the side ...

Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side ...

The woman was accused of selling counterfeit versions of popular weight loss drugs including Ozempic and Wegovy. Experts say ...

Eli Lilly & Co.’s diabetes and weight-loss drugs Mounjaro and Zepbound are no longer in short supply in the US, which means ...